Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Gastroenterology Clinics of North America|October 15, 2003
Managing gastroesophageal reflux disease: from pharmacology to the clinical arenaM Michael WolfeCurrent Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Gastrointestinal regulatory peptides: an overviewM Michael WolfeInternational Journal of Clinical Practice. Supplement|May 2, 2003
Risk factors associated with the development of gastroduodenal ulcers due to the use of NSAIDsM Michael WolfeRheumatic Diseases Clinics of North America|November 8, 2003
Gastroprotection by coxibs: what do the Celecoxib Long-Term Arthritis Safety Study and the Vioxx Gastrointestinal Outcomes Research Trial tell us?Jaime A Oviedo, M Michael WolfeCurrent Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Glucose-dependent insulinotropic polypeptide and its role in obesityDiane H Song, M Michael WolfeJournal of Clinical Gastroenterology|May 16, 2014
Obesity and the gastrointestinal tract: you are what you eatM Michael Wolfe, Michael O BoylanThe Journal of Biological Chemistry|April 1, 2006
Attenuation of peroxisome proliferator-activated receptor gamma (PPARgamma) mediates gastrin-stimulated colorectal cancer cell proliferationAlbert J Chang, Diane H Song, M Michael WolfeAmerican Journal of Physiology. Endocrinology and Metabolism|January 13, 2006
Sp1/Sp3 binding is associated with cell-specific expression of the glucose-dependent insulinotropic polypeptide receptor geneMichael O Boylan, Lisa I Jepeal, M Michael WolfeObesity (Silver Spring, Md.)|May 19, 2023
Glucose-dependent insulinotropic polypeptide monoclonal antibodies prevent and treat obesity in wild-type and hyperphagic miceM Michael Wolfe, Caroline M Apovian, Michael O BoylanEndocrine Reviews|February 14, 2025
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and DiseaseM Michael Wolfe, Michael O Boylan, Wiliam W ChinPageof 4